The Effect of Curcumin (turmeric) on Alzheimer's Disease: An Overview

Overview

Journal Ann Indian Acad Neurol

Specialty Neurology

Date 2009 Dec 8

PMID 19966973

Citations 143

Authors

Shrikant Mishra

Kalpana Palanivelu

Affiliations

Soon will be listed here.

Abstract

This paper discusses the effects of curcumin on patients with Alzheimer's disease (AD). Curcumin (Turmeric), an ancient Indian herb used in curry powder, has been extensively studied in modern medicine and Indian systems of medicine for the treatment of various medical conditions, including cystic fibrosis, haemorrhoids, gastric ulcer, colon cancer, breast cancer, atherosclerosis, liver diseases and arthritis. It has been used in various types of treatments for dementia and traumatic brain injury. Curcumin also has a potential role in the prevention and treatment of AD. Curcumin as an antioxidant, anti-inflammatory and lipophilic action improves the cognitive functions in patients with AD. A growing body of evidence indicates that oxidative stress, free radicals, beta amyloid, cerebral deregulation caused by bio-metal toxicity and abnormal inflammatory reactions contribute to the key event in Alzheimer's disease pathology. Due to various effects of curcumin, such as decreased Beta-amyloid plaques, delayed degradation of neurons, metal-chelation, anti-inflammatory, antioxidant and decreased microglia formation, the overall memory in patients with AD has improved. This paper reviews the various mechanisms of actions of curcumin in AD and pathology.

Citing Articles

Exploring the molecular mechanisms of curcumin in modulating memory impairment in neurodegenerative disorders.

Baghcheghi Y, Razazpour F, Mirzaee F, Dalfardi M, Pourfridoni M, Hedayati-Moghadam M Mol Biol Rep. 2024; 52(1):45.

PMID: 39653966 DOI: 10.1007/s11033-024-10115-5.

Green synthesis of nanoparticles using medicinal plants as an eco-friendly and therapeutic potential approach for neurodegenerative diseases: a comprehensive review.

Izadi R, Bahramikia S, Akbari V Front Neurosci. 2024; 18:1453499.

PMID: 39649663 PMC: 11621856. DOI: 10.3389/fnins.2024.1453499.

Molecular and Cellular Foundations of Aging of the Brain: Anti-aging Strategies in Alzheimer's Disease.

Dziewa M, Zlotek M, Herbet M, Piatkowska-Chmiel I Cell Mol Neurobiol. 2024; 44(1):80.

PMID: 39607636 PMC: 11604688. DOI: 10.1007/s10571-024-01514-0.

Exploring the multifaceted functions of APPL in metabolism and memory using Drosophila melanogaster.

Nath D, Lee Y Mol Cells. 2024; 48(1):100163.

PMID: 39603510 PMC: 11697555. DOI: 10.1016/j.mocell.2024.100163.

Establishing network pharmacology between natural polyphenols and Alzheimer's disease using bioinformatic tools - An advancement in Alzheimer's research.

Subramanian A, Tamilanban T, Subramaniyan V, Sekar M, Kumar V, Janakiraman A Toxicol Rep. 2024; 13:101715.

PMID: 39280991 PMC: 11402327. DOI: 10.1016/j.toxrep.2024.101715.

References

Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas P . Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998; 64(4):353-6. DOI: 10.1055/s-2006-957450. View

Soni K, Kuttan R . Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian J Physiol Pharmacol. 1992; 36(4):273-5. View

Ireson C, Jones D, Orr S, Coughtrie M, Boocock D, Williams M . Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev. 2002; 11(1):105-11. View

Jorm A, Jolley D . The incidence of dementia: a meta-analysis. Neurology. 1998; 51(3):728-33. DOI: 10.1212/wnl.51.3.728. View

Shishodia S, Sethi G, Aggarwal B . Curcumin: getting back to the roots. Ann N Y Acad Sci. 2006; 1056:206-17. DOI: 10.1196/annals.1352.010. View

Bamberger M, Landreth G . Inflammation, apoptosis, and Alzheimer's disease. Neuroscientist. 2002; 8(3):276-83. DOI: 10.1177/1073858402008003013. View

Mythri R, Jagatha B, Pradhan N, Andersen J, Srinivas Bharath M . Mitochondrial complex I inhibition in Parkinson's disease: how can curcumin protect mitochondria?. Antioxid Redox Signal. 2006; 9(3):399-408. DOI: 10.1089/ars.2006.1479. View

Garcia-Alloza M, Borrelli L, Rozkalne A, Hyman B, Bacskai B . Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem. 2007; 102(4):1095-104. DOI: 10.1111/j.1471-4159.2007.04613.x. View

Ammon H, Wahl M . Pharmacology of Curcuma longa. Planta Med. 1991; 57(1):1-7. DOI: 10.1055/s-2006-960004. View

10.

Giri R, Rajagopal V, Kalra V . Curcumin, the active constituent of turmeric, inhibits amyloid peptide-induced cytochemokine gene expression and CCR5-mediated chemotaxis of THP-1 monocytes by modulating early growth response-1 transcription factor. J Neurochem. 2004; 91(5):1199-210. DOI: 10.1111/j.1471-4159.2004.02800.x. View

11.

Ng T, Chiam P, Lee T, Chua H, Lim L, Kua E . Curry consumption and cognitive function in the elderly. Am J Epidemiol. 2006; 164(9):898-906. DOI: 10.1093/aje/kwj267. View

12.

Park S, Kim D . Discovery of natural products from Curcuma longa that protect cells from beta-amyloid insult: a drug discovery effort against Alzheimer's disease. J Nat Prod. 2002; 65(9):1227-31. DOI: 10.1021/np010039x. View

13.

Yang F, Lim G, Begum A, Ubeda O, Simmons M, Ambegaokar S . Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem. 2004; 280(7):5892-901. DOI: 10.1074/jbc.M404751200. View

14.

Zhang L, Fiala M, Cashman J, Sayre J, Espinosa A, Mahanian M . Curcuminoids enhance amyloid-beta uptake by macrophages of Alzheimer's disease patients. J Alzheimers Dis. 2006; 10(1):1-7. DOI: 10.3233/jad-2006-10101. View

15.

Ringman J, Frautschy S, Cole G, Masterman D, Cummings J . A potential role of the curry spice curcumin in Alzheimer's disease. Curr Alzheimer Res. 2005; 2(2):131-6. PMC: 1702408. DOI: 10.2174/1567205053585882. View

16.

Perry G, Sayre L, Atwood C, Castellani R, Cash A, Rottkamp C . The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications. CNS Drugs. 2002; 16(5):339-52. DOI: 10.2165/00023210-200216050-00006. View

17.

Fiala M, Liu P, Espinosa-Jeffrey A, Rosenthal M, Bernard G, Ringman J . Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin. Proc Natl Acad Sci U S A. 2007; 104(31):12849-54. PMC: 1937555. DOI: 10.1073/pnas.0701267104. View

18.

Baum L, Ng A . Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models. J Alzheimers Dis. 2004; 6(4):367-77. DOI: 10.3233/jad-2004-6403. View

19.

Ganguli M, Chandra V, Kamboh M, Johnston J, Dodge H, Thelma B . Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study. Arch Neurol. 2000; 57(6):824-30. DOI: 10.1001/archneur.57.6.824. View

20.

Frautschy S, Hu W, Kim P, Miller S, Chu T, Harris-White M . Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol Aging. 2002; 22(6):993-1005. DOI: 10.1016/s0197-4580(01)00300-1. View